Merve Ay

Dr. Merve Ay


Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 June 2026 in Biomedicines
Verified
Journal Article
Open access
PDF file
Murat AYMurat AY
Murat AY
SOSemiha Orhan
Semiha Orhan
NDNese Demirtürk
Nese Demirtürk
EBErhan Bozkurt
Erhan Bozkurt
ASAlper Sari
Alper Sari
MAMerve Ay
Merve Ay
Background/Objectives: We investigated the association of serum ferritin and procalcitonin (PCT) with Sepsis-related Organ Failure Assessment (SOFA)-2 score-based organ dysfunction severity in intensive care patients with COVID-19-associated sepsis. Methods: Patients were stratified by day 5 ferritin (ng/mL) and PCT (μg/L) levels; associations were analysed across severity groups defined by an SOFA-2 score of <5 (mild) or ≥5 (severe). Results: Day 5 PCT did not predict the SOFA-2 score (p > 0.05). The optimal day 5 ferritin cut-off was >1191 ng/mL (35.78% sensitivity, 82.38% specificity; area under the curve (AUC) = 0.608). Day 5 ferritin was associated with SOFA-2 severity in the univariable analysis but did not remain an independent correlate after adjustment for C-reactive protein (CRP) and lactate dehydrogenase (LDH); in a mortality model, neither ferritin nor PCT independently predicted intensive care unit (ICU) death. PCT provided no predictive value beyond existing inflammatory markers, consistent with its suppression during viral infections. Conclusions: Day 5 ferritin reflects, rather than independently predicts, organ dysfunction severity and may complement, rather than replace, established multi-parameter scoring. Relative to the independent determinants of severity and mortality (PaO2/FiO2 ratio, LDH, CRP, and age), day 5 ferritin is a specific, rule-in adjunctive marker of concurrent organ dysfunction rather than a standalone prognostic tool. Whether these associations extend to non-COVID sepsis populations requires prospective study.

28 May 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
Murat AYMurat AY
Murat AY
SOSemiha Orhan
Semiha Orhan
NDNese Demirtürk
Nese Demirtürk
EBErhan Bozkurt
Erhan Bozkurt
ASAlper Sari
Alper Sari
MAMerve Ay
Merve Ay
Background/Objectives: To our knowledge, this is the first study to simultaneously investigate the prognostic value of serum ferritin and procalcitonin (PCT) in relation to (SOFA)-2 score-based organ dysfunction severity in intensive care patients diagnosed with COVID-19-associated sepsis. Methods: Patients were stratified based on day 5 ferritin (ng/mL) and PCT levels (μg/L). Prognostic performance was analysed across severity groups defined by (SOFA)-2 score of 0.05). The optimal day 5 ferritin cut-off was >1,191 ng/mL, with 35.78% sensitivity and 82.38% specificity (AUC = 0.608). Elevated ferritin levels may help identify patients at higher risk of adverse outcomes who may benefit from closer monitoring or intensive care escalation. By contrast, PCT did not provide additional predictive value for organ dysfunction severity in COVID-19 beyond existing inflammatory markers, consistent with its known suppression during primary viral infections. Conclusions: Serum ferritin showed a significant positive association with (SOFA)-2 score, supporting its role as a clinically relevant biomarker for disease stratification in COVID-19-associated sepsis. These findings may extend to non-COVID sepsis populations where macrophage activation and iron dysregulation drive organ dysfunction.

19 August 2026 in Life
Verified
Journal Article
Open access
PDF file
SOSemiha Orhan
Semiha Orhan
Murat AYMurat AY
Murat AY
MAMerve Ay
Merve Ay
KGKemal Yetis Gulsoy
Kemal Yetis Gulsoy
Background/Objectives: This study aimed to evaluate the associations of adding oXiris hemoadsorption therapy to standard sepsis treatment with inflammatory markers, organ dysfunction, hemodynamic parameters, respiratory function, and overall survival (OS) in patients with sepsis and septic shock managed in the intensive care unit (ICU). In our ICU, oXiris was used as adjunctive hemoadsorption for endotoxin and cytokine removal, delivered on a continuous venovenous hemodiafiltration (CVVHDF) platform and initiated independently of acute kidney injury (AKI). Methods: This retrospective comparative cohort study included 83 adult patients with sepsis or septic shock admitted to the Internal Medicine ICU. Patients were allocated to either the oXiris group (n = 33), which received oXiris hemoadsorption for 72 h in addition to standard sepsis therapy, or the control group (n = 50), which received standard sepsis therapy without oXiris or another adsorptive CRRT membrane. Conventional intermittent hemodialysis for independent renal indications was permitted and recorded in both groups. C-reactive protein (CRP), procalcitonin (PCT), white blood cell count, updated Sequential Organ Failure Assessment (SOFA-2) score, PaO2/FiO2 ratio, serum lactate, norepinephrine dose, and renal parameters were recorded at baseline, 48 h, and 72 h. Between-group differences in temporal changes were evaluated using adjusted generalized estimating equation models, and robustness was assessed with a propensity-score-based inverse-probability-of-treatment-weighted (IPTW) sensitivity analysis. Survival analysis was performed using the Kaplan–Meier method and log-rank test. Results: The oXiris group had significantly greater baseline clinical severity, including a higher burden of renal dysfunction. This marked baseline imbalance was considered important when interpreting the unadjusted findings and supported the use of adjusted and IPTW analyses. In the oXiris group, CRP, PCT, SOFA-2 score, and norepinephrine requirement showed greater reductions over time, whereas the PaO2/FiO2 ratio improved significantly. After IPTW adjustment, the between-group differences in SOFA-2 score, norepinephrine requirement, and PaO2/FiO2 ratio remained statistically significant, whereas the CRP and PCT differences were no longer statistically significant. Serum lactate levels showed an increasing trend in the oXiris group compared with the control group (p = 0.042). No significant difference in overall survival was observed between the two groups (p = 0.897). Conclusions: The addition of oXiris hemoadsorption to standard sepsis therapy was associated with favorable early temporal changes in organ dysfunction, norepinephrine requirement, and oxygenation. However, the observed CRP and PCT differences were not preserved after IPTW adjustment, and no survival association was identified. These findings should therefore be interpreted as associations rather than evidence of a causal treatment effect.